Welcome the Future of Biopharmaceutics
Explore strategies, regulatory validation, and solutions through case studies in small-molecule human Physiologically Based Pharmacokinetic modeling (PBPK).
What you’ll learn
- How PBPK modeling and simulation save time and money while improving internal decision-making processes.
- Case studies illustrating the increased adoption of Model Informed Drug Development (MIDD) and Model Informed Formulation Development (MIFD), using the Simcyp Simulator PBPK platform.
- Biosimulation’s growing acceptance in regulatory decision making.